Xueqin Chen

机构：Central South University, Sir Run Run Shaw Hospital, Westlake University, Hubei University of Science and Technology, Qujing Normal University, National Engineering Research Center of Human Stem Cells, Ningbo University Affiliated Hospital, Ningbo First Hospital, Zhejiang University · ORCID：0000-0002-1828-1985

发表论文 230 篇 · 总被引 3190 次 · h-index 29

代表论文

• β-resorcylic acid released by Limosilactobacillus reuteri protects against cisplatin-induced ovarian toxicity and infertility (2024 · Cell Reports Medicine · 被引 10)
• The structural basis of TRIM25-mediated regulation of RIG-I (2025 · Journal of Biological Chemistry · 被引 9)
• Discovery of Novel Pyrimidine-Based Derivatives as Nav1.2 Inhibitors with Efficacy in Mouse Models of Epilepsy (2024 · Journal of Medicinal Chemistry · 被引 8)
• Pharmacological rescue of mutant p53 triggers spontaneous tumor regression via immune responses (2025 · Cell Reports Medicine · 被引 5)
• Conformational restriction enables discovering a series of chroman derivatives as potent and selective NaV1.8 inhibitors with improved pharmacokinetic properties (2025 · European Journal of Medicinal Chemistry · 被引 4)
• Disturbing Cholesterol/Sphingolipid Metabolism by Squalene Epoxidase Arises Crizotinib Hepatotoxicity (2025 · Advanced Science · 被引 4)